Pierce K D, Furlong T J, Selbie L A, Shine J
Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, N.S.W., Australia.
Biochem Biophys Res Commun. 1992 Aug 31;187(1):86-93. doi: 10.1016/s0006-291x(05)81462-7.
A novel receptor cDNA was isolated from a human hippocampal cDNA library. The encoded polypeptide contains structural features consistent with its classification as a G protein-coupled receptor and shares 45% homology with the human A1 and A2a adenosine receptors. Chinese hamster ovary K1 cells expressing this receptor showed marked stimulation of adenylate cyclase when treated with 1mM adenosine. There was no response to ligands selective for A1 and A2a receptors but the general adenosine agonist N-ethylcarboxyamidoadenosine (NECA) caused a 10 fold increase in cyclic AMP accumulation with an EC50 of approximately 0.9 microM. This effect was inhibited by the adenosine receptor antagonist theophylline. Specific binding of A1 and A2a selective agonists and NECA was not detected. It is proposed that the novel receptor is a human brain adenosine A2b receptor subtype.
从人脑海马体cDNA文库中分离出一种新型受体cDNA。编码的多肽包含的结构特征与其作为G蛋白偶联受体的分类一致,并且与人类A1和A2a腺苷受体具有45%的同源性。表达该受体的中国仓鼠卵巢K1细胞在用1mM腺苷处理时显示出腺苷酸环化酶的显著激活。对A1和A2a受体选择性的配体无反应,但一般的腺苷激动剂N-乙基羧酰胺基腺苷(NECA)使环磷酸腺苷积累增加10倍,EC50约为0.9微摩尔。腺苷受体拮抗剂茶碱抑制了这种效应。未检测到A1和A2a选择性激动剂及NECA的特异性结合。有人提出该新型受体是一种人脑腺苷A2b受体亚型。